CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-16 | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | Exercise or conversion · Restricted Stock Unit | −15,062 | 66,997 | ||
| 2024-01-16 | O'NEIL PATRICK R. EVP CLO & General Counsel | Exercise or conversion | +20,641 | 60,996 | ||
| 2024-01-16 | O'NEIL PATRICK R. EVP CLO & General Counsel | Exercise or conversion · Restricted Stock Unit | −20,641 | 47,414 | ||
| 2024-01-16 | Birchler Brian EVP, Corp and Development Ops | Exercise or conversion | +12,080 | 49,079 | ||
| 2024-01-16 | Birchler Brian EVP, Corp and Development Ops | Exercise or conversion · Restricted Stock Unit | −12,080 | 46,248 | ||
| 2024-01-16 | Swayze Eric EVP Research | Exercise or conversion | +17,069 | 49,585 | ||
| 2024-01-16 | Swayze Eric EVP Research | Exercise or conversion | +21 | 94 | ||
| 2024-01-16 | Swayze Eric EVP Research | Exercise or conversion · Restricted Stock Unit | −17,069 | 46,728 | ||
| 2024-01-16 | Swayze Eric EVP Research | Exercise or conversion · Restricted Stock Unit | −21 | 551 | ||
| 2024-01-16 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Exercise or conversion | +15,162 | 53,332 | ||
| 2024-01-16 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Exercise or conversion · Restricted Stock Unit | −15,162 | 45,308 | ||
| 2024-01-16 | Monia Brett P Chief Executive Officer | Exercise or conversion | +68,084 | 186,195 | ||
| 2024-01-16 | Monia Brett P Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −68,084 | $10.00 | $681K | 196,212 |
| 2024-01-16 | HOUGEN ELIZABETH L EVP, Finance & CFO | Exercise or conversion | +22,487 | 99,573 | ||
| 2024-01-16 | HOUGEN ELIZABETH L EVP, Finance & CFO | Exercise or conversion · Restricted Stock Unit | −22,487 | 62,056 | ||
| 2024-01-16 | Geary Richard S EVP, Chief Development Officer | Exercise or conversion | +19,852 | 92,813 | ||
| 2024-01-16 | Geary Richard S EVP, Chief Development Officer | Exercise or conversion · Restricted Stock Unit | −19,852 | 46,625 | ||
| 2024-01-16 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion | +18,314 | 84,068 | ||
| 2024-01-16 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion · Restricted Stock Unit | −18,314 | 23,500 | ||
| 2024-01-16 | Baroldi Joseph EVP, Chief Business Officer | Exercise or conversion | +3,688 | 14,259 |
Page 42 of 44 · 873 trades